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Abstract 
A simple UV spectroscopic method was developed and validated for the estimation of Ilaprazole in 
bulk and pharmaceutical dosage form using Acetonitrile: ethanol (50:50) as solvent. The quantification was 
achieved at 307nm. Beers law was obeyed in the concentration range of 2-12 μg/ml. The results of analysis 
have been validated statistically and recovery studies carried out in the range 80-120% to confirm the accuracy 
of the proposed method. The relative standard deviation was found to be less than 2.0%. The present result 
shows that the proposed method can be successfully implemented for estimation of Ilaprazole in bulk and its 
marketed formulations. 
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1. Introduction 
 Ilaprazole is a proton pump inhibitor
 [1-4] 
(PPI) used in the treatment of dyspepsia, Peptic ulcer 
disease (PUD), gastro esophageal reflux 
disease (GORD/GERD) and duodenal ulcers.  
         Chemically
2
 it is 2-[(RS)-[(4-methoxy-3-
methylpyridin-2yl) methyl] sulfinyl]-5-(1H-pyrrol-1-
yl)-1H-benzimidazole. It suppresses gastric acid 
secretion by specific inhibition of the H+/K+-ATPase 
in the gastric parietal cell by acting specifically on 
the proton pump; Thus Ilaprazole blocks the acid 
production and help in reducing gastric acidity. 
 
Literature review reveals that some of the 
UV 
[5-8]
, HPLC
 [9]
, UPLC
 [10] 
methods have been 
reported for the estimation of Ilaprazole. Very few 
assay indicating methods are reported; hence the 
present work has made an attempt for quantification 
of Ilaprazole individually in its bulk and tablet 
formulation by UV spectroscopy as per ICH 
guidelines. 
 
2. Materials and Methods 
2.1 Instrumentation 
Absorption spectral measurements were 
carried out with a UV – Visible spectrophotometer 
(T60 PG instruments & T190 shimadzu) with spectral 
bandwidth of 1 nm and wavelength accuracy of 0.3 
nm (with automatic wavelength correction with a pair 
of 5 cm matched quartz cells. 
2.2 Chemicals 
Acetonitrile & Ethanol used for dilution was 
of analytical grade. Ilaprazole is a marketed sample 
manufactured by SIDCO, kartholi Ltd. All other 
ingredients used were of analytical grade 
2.3 Preparation of Standard stock solution 
10mg of standard Ilaprazole drug was 
weighed accurately and taken in a clean and dry 
volumetric flask. The drug was dissolved in some 
amount of Solvent (Acetonitrile: Ethanol) and made 
upto the mark with the same solvent. This gives 
1000µg/ml solution. From this solution 1ml was 
taken and transferred to a 10ml volumetric flask and 
the volume was made up to the mark by using solvent 
resulting to a concentration of 100µg/ml. Next again 
a 1ml of solution was taken from above dilution in 
10ml volumetric flask and made up to 10ml this give 
concentration of 10µg/ml. 
2.4 Preparation of Test solution 
Twenty tablets of formulation were weighed 
and finely powdered. The powder equivalent to 10 
mg of Ilaprazole was accurately weighed. It was then 
transferred to volumetric flask of 10 ml capacity 
containing 5 ml of solvent and sonicated for 5 min. 
The flask was shaken and the solution was filtered 
through Whatmann filter paper (No. 41) into 10 ml 
volumetric flask. Volume was made up to the mark 
with solvent to give a solution of 1000 μg/ml (Stock 
solution A). From this stock solution A, 1 ml was 
taken and placed in 10 ml volumetric flask. The 
volume was made up to the mark using solvent to 
give a solution of 100 μg/ml (Stock solution B). From 
the stock solution B, 1ml was taken and diluted to 10 
ml to give 10 μg/ml. 
2.5 Selection of λ max 
           The solution of 10 μg/ml was prepared from 
standard stock solution and the prepared diluted 
solution was scanned by using UV-Visible 
spectrophotometer from the range between 200nm-
400nm on spectrum mode, using proper solvent 
(Acetonitrile: Ethanol).The UV spectrum had shown 
highest peak at 307nm. Hence 307nm was selected as 
λ max for analysis. 
Fig no: 1 UV spectrum of Ilaprazole 
 
2.6 Validation parameters
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Linearity 
A linear relationship should be evaluated 
across the range of the analytical procedure. It was 
demonstrated directly on the drug substance (by 
dilution of a standard stock solution) and using the 
proposed procedure. 
Accuracy 
          Accuracy was established across the 
specified range of the analytical procedure. Accuracy 
is the closeness of the test results obtained by the 
method to the true value. Recovery studies were 
carried out by addition of standard drug to the sample 
at 3 different concentration levels taking into 
consideration percentage purity of added bulk drug 
samples. 
Precision  
Precision was determined as repeatability 
and interday and intraday precision, in accordance 
with ICH guidelines. Variation of results within the 
day (intraday), variation of results between the days 
(interday) was analyzed. Intraday precision was 
determined by analyzing Ilaprazole for six times in 
the same day at 307nm. 
          Inter day precision was determined by 
analyzing the drug for three different days at 307nm. 
 
3. Results and Discussions 
Linearity 
In this method Ilaprazole was estimated by 
using ultraviolet spectroscopy. The method obeys 
Beer lamberts law in the concentration range of 2-
12μg/ml and its wavelength of detection was 307nm. 
Correlation coefficients of Ilaprazole were found to 
be 0.999 with a straight line equation 
Y=0.033X+0.033. The absorbance values are given 
in Table 1 and figure 2 indicates that the method is 
linear.  
 
Table 1: Linearity Results 
S. No Concentration Absorbance 
Standard Sample 
1 2 0.098 0.07 
2 4 0.154 0.12 
3 6 0.219 0.2 
4 8 0.271 0.27 
5 10 0.332 0.33 
6. 12 0.379 0.38 
 
Fig No: 2 Linearity curve of Ilaprazole 
 
 
 
Accuracy 
The accuracy of the proposed methods was 
assessed by recovery studies at three different levels 
i.e. 80%, 100%, 120%. The values of recovery (%), 
RSD (%) listed in Table 2 indicate the method is 
accurate. 
 
Table 2: Results of Accuracy Studies by UV spectroscopy 
S. No Concentration Absorbance % Assay 
Standard Sample 
1 80% 0.318 0.317 99.6 
2 80% 0.319 0.320 100 
3 80% 0.320 0.319 99.6 
1 100% 0.352 0.350 99.4 
2 100% 0.351 0.354 100.8 
3 100% 0.354 0.352 99.4 
1 120% 0.411 0.412 100.2 
2 120% 0.410 0.409 99.5 
3 120% 0.411 0.410 99.7 
Arithmetic Mean 99.7 
 Standard deviation 0.1 
% Relative Standard Deviation 0.01 
 
Precision 
The intra & inter day variation of the 
method was carried out and the standard deviation 
and % RSD (% RSD < 2%) within a day and day to 
day variations for Ilaprazole  listed in Table 3 and 
Table 4 ,indicates the proposed method is precise. 
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Table 3: Results for Intraday Precision 
S. No Absorbance 
% Assay 
 Standard Sample 
0
th
  hour 0.352 0.335 95.1 
1
st
  hour 0.341 0.340 100.2 
2
nd
  hour 0.342 0.343 99.4 
Arithmetic Mean 98.2 
Standard Deviation 38.4 
% Relative Standard Deviation 0.039 
 
Table 4: Results for Interday Precision 
S. No Absorbance % Assay 
Standard Sample 
Day 1 0.352 0.350 99.4 
Day 2 0.369 0.365 98.9 
Arithmetic Mean 99.1 
Standard Deviation 0.94 
% Relative Standard Deviation 0.009 
 
Robustness 
The spectrophotometry method shows that 
developed method was robust. the robustness was 
performed by different analysts (analyst-I and 
analyst-II), different wavelengths (305nm & 309nm) 
and different instruments (T60 pg instruments & 
T190 shimadzu) in the same laboratory by estimating 
the multiple samples of single concentration. 
 
Differential Wavelength: 
Table 5: Differential Wavelength values for standard and sample 
S. No Absorbance 
%Assay 
 
 
 305nm 
Standard Sample 
0.276 0.275 100.3 
0.274 0.273 99.6 
0.278 0.278 100.7 
 
 309nm 
0.413 0.413 100.4 
0.412 0.412 99.7 
0.415 0.415 100.4 
Arithmetic  Mean 100.1 
Standard Deviation 0.1 
%Relative Standard Deviation 0.01 
 
        Differential Analyst: 
 
Table 6: Differential Analyst values for standard and sample 
 
S. No Absorbance 
% Assay 
Analyst 1 Standard Sample 
0.351 0.353 100.5 
0.351 0.354 100.8 
0.352 0.357 101.4 
Analyst 2 0.355 0.354 99.7 
0.354 0.357 100.8 
0.358 0.356 99.4 
Arithmetic  Mean 100.4 
Standard Deviation 0.8 
%Relative Standard Deviation 0.007 
 
Differential Instrument: 
 
Table 7: Differential Instrument values for standard and sample 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
S. No Absorbance % Assay 
Analyst 1 Standard Sample  
0.351 0.350 99.7 
0.352 0.353 100.2 
0.351 0.351 100 
Analyst 2 0.352 0.350 99.4 
0.352 0.352 100 
0.351 0.353 100.5 
Arithmetic  Mean 99.7 
Standard Deviation 0.14 
%Relative Standard Deviation 0.001 
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4. Conclusion 
          The proposed method was found to be simple, 
selective and sensitive. The validation parameters 
were also found to be within the limits. The method 
showed acceptable linearity and accuracy and is 
highly sensitive therefore it could be used easily for 
the routine analysis of pure drugs and their 
formulations for Ilaprazole. 
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